Husni Zulhilmi, Ismail Sabariah, Zulkiffli Mohd Halimhilmi, Afandi Atiqah, Haron Munirah
Centre for Drug Research, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Pharmacogn Mag. 2017 Jul;13(Suppl 2):S236-S243. doi: 10.4103/pm.pm_299_16. Epub 2017 Jul 11.
, , and are commonly consumed as herbal medicines. However their effects on human liver glucuronidation activity are not yet evaluated.
In this study, we evaluate the inhibitory Effects of Andrographis paniculata, Gynura procumbens, Ficus deltoidea and Curcuma xanthorrhiza extracts and their constituents on human liver glucuronidation activity.
Herbal extracts (aqueous, methanolic and ethanolic extracts) and their constituents were incubated with human liver microsomes with the addition of UDPGA to initiate the reaction. Working concentrations of herbal extracts and their constituents ranged from 10 μg/mL to 1000 μg/mL and 10 μM to 300 μM respectively. IC50 was determined by monitoring the decrement of glucuronidation activity with the increment of herbal extracts or phytochemical constituent's concentrations.
All herbal extracts inhibited human liver glucuronidation activity in range of 34.69 μg/mL to 398.10 μg/mL whereas for the constituents, only xanthorrhizol and curcumin (constituents of ) inhibited human liver glucuronidation activity with IC50 of 538.50 and 32.26 μM respectively.
In the present study, we have proved the capabilities of , , and to interfere with glucuronidation process in human liver microsomes.
This study documented the capabilities of , , and to inhibit human liver glucuronidation activity which may affect the metabolism of therapeutic drugs or hazardous toxicants that follow the same glucuronidation pathway. UGT: Uridine 5'-diphospho-glucuronosyltransferase; 4-MU: 4-methylumbelliferone; IC50: Half Maximal Inhibitory Concentration; Km: Michaelis constant; Vmax: Maximum velocity.
穿心莲、白凤菜、三角叶榕和郁金通常作为草药使用。然而,它们对人肝脏葡萄糖醛酸化活性的影响尚未得到评估。
在本研究中,我们评估了穿心莲、白凤菜、三角叶榕和郁金提取物及其成分对人肝脏葡萄糖醛酸化活性的抑制作用。
将草药提取物(水提取物、甲醇提取物和乙醇提取物)及其成分与人肝微粒体一起孵育,并添加尿苷二磷酸葡萄糖醛酸(UDPGA)以启动反应。草药提取物及其成分的工作浓度分别为10μg/mL至1000μg/mL和10μM至300μM。通过监测随着草药提取物或植物化学成分浓度增加葡萄糖醛酸化活性的降低来确定半数最大抑制浓度(IC50)。
所有草药提取物在34.69μg/mL至398.10μg/mL范围内抑制人肝脏葡萄糖醛酸化活性,而对于其成分,只有莪术烯醇和姜黄素(郁金的成分)抑制人肝脏葡萄糖醛酸化活性,IC50分别为538.50和32.26μM。
在本研究中,我们证明了穿心莲、白凤菜、三角叶榕和郁金干扰人肝微粒体中葡萄糖醛酸化过程的能力。
本研究记录了穿心莲、白凤菜、三角叶榕和郁金抑制人肝脏葡萄糖醛酸化活性的能力,这可能会影响遵循相同葡萄糖醛酸化途径的治疗药物或有害毒物的代谢。UGT:尿苷5'-二磷酸葡萄糖醛酸基转移酶;4-MU:4-甲基伞形酮;IC50:半数最大抑制浓度;Km:米氏常数;Vmax:最大速度。